Skip to contentR
Rigel Pharmaceuticals Inc
R
RIGLRigel Pharmaceuticals Inc Released Mar 3, 2015, during market hours
10-K filed Mar 3, 2015, 62 days after period end · 0001047469-15-001563
Q4 2014 · 10-K
Revenue—
Net income—
EPS Diluted-$0.25-$0.25N/M vs Q4 2013 No earnings release is on file for this quarter. Its figures came with the 10-K.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Rigel Pharmaceuticals Inc · CIK 1034842 · Engraved from SEC EDGAR
N/M vs Q3 2014
Operating Incomederived-$22,368,000N/M Operating Cash Flowderived-$15,050,000N/M Free Cash Flowderived-$15,204,000N/M ended Dec 31, 2014 · filed Mar 3, 2015 · 62 d after period end
+3.0% from the close of Feb 27, 2015 to the close of Mar 4, 2015, the first after the release.
during market hours$2.99$3.08 Jan 16Mar 3Apr 1